IL6 and Sepsis: Notably, the administration of soluble gp130-Fc (sgp130-Fc), which selectively inhibits IL-6 trans-signaling, improved mortality in a CLP model through the abrogation of epithelial cell apoptosis70, whereas IL-6 neutralization did not improve mortality in a sepsis model71,72.